Olamufloxacin. Hokuriku Seiyaku.
作者信息
Jiraskova N
机构信息
Charles University Hospital, Department of Ophthalmology, 500 05 Hradec, Kralove, Czech Republic.
出版信息
Curr Opin Investig Drugs. 2000 Sep;1(1):31-4.
PMID:11249592
Abstract
Hokuriku is developing olamufloxacin, a quinolone antibiotic that inhibits DNA gyrase, for the potential treatment of various types of bacterial infection. It has reached late phase II clinical trials. An intravenous formulation is also under investigation [277817].
摘要
Zotero 插件